CMIC Holdings and Median Technologies venture into agreement ensuring Clinical Trial Services Read more
Longeveron commenced treatment of first Left Heart Syndrome patient using mesenchymal stem cell therapy Read more
PharmaCyte declares completion of 6-Month Stability Study on Encapsulated Cells for Clinical Trial Read more